Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.

Uchino, Yoshihiro; Muroya, Daisuke; Yoshitomi, Munehiro; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Yamada, Teppei; Okuda, Koji; Itoh, Kyogo; Yutani, Shigeru

Uchino, Yoshihiro; Muroya, Daisuke; Yoshitomi, Munehiro; Shichijo, Shigeki; Yamada, Akira; Sasada, Tetsuro; Yamada, Teppei; Okuda, Koji; Itoh, Kyogo; Yutani, Shigeru.

Afiliação

Uchino Y; Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 839-0823, Japan.
Muroya D; Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Yoshitomi M; Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Shichijo S; Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Yamada A; Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 839-0823, Japan.
Sasada T; Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume University, Kurume, Fukuoka 830-0011, Japan.
Yamada T; Cancer Vaccine and Immunotherapy Center, Kanagawa Cancer Center Research Institute, Kanagawa, Yokohama 241-8515, Japan.
Okuda K; Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka 814-0180, Japan.
Itoh K; Department of Surgery, Kurume University School of Medicine, Kurume, Fukuoka 830-0011, Japan.
Yutani S; Cancer Vaccine Center, Kurume University, Kurume, Fukuoka 839-0823, Japan.